ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,468Medicare Part D Prescriptions Filled, Including Refills

Rank: 384 out of 2094

$480K Total Retail Price of All Prescriptions

Rank: 530 out of 2094

354 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 354 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,078 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 453 388 1 2
METFORMIN HCL 412 325 2 8
LISINOPRIL 255 240 3 7
NAPROXEN 240 196 4 84
SIMVASTATIN 231 207 5 1
ATORVASTATIN CALCIUM 209 187 6 5
METOPROLOL SUCCINATE 181 179 7 9
METOPROLOL TARTRATE 163 150 8 10
FUROSEMIDE 149 132 9 6
OMEPRAZOLE 149 110 9 4
DIOVAN HCT 130 108 11 28
QUINAPRIL HCL 125 125 12 123
DONEPEZIL HCL 120 120 13 20
CLOPIDOGREL 107 97 14 22
GLIPIZIDE XL 104 84 15 122
IBUPROFEN 92 32 16 73
GLIMEPIRIDE 90 90 17 31
HYDROCHLOROTHIAZIDE 88 79 18 12
DIOVAN 88 67 18 13
TRAMADOL HCL 87 79 20 33
LEVOTHYROXINE SODIUM 85 63 21 3
ENALAPRIL MALEATE 85 61 21 25
PLAVIX 83 80 23 38
CRESTOR 83 68 23 15
NEXIUM 82 76 25 16
RAMIPRIL 77 59 26 48
LIPITOR 75 64 27 39
PROAIR HFA 74 58 28 45
OXYCODONE-ACETAMINOPHEN 74 67 S2 28 40
AMLODIPINE BESYLATE-BENAZEPRIL 73 53 30 58
WARFARIN SODIUM 66 41 31 11
AZITHROMYCIN 61 40 32 27
DOXAZOSIN MESYLATE 59 59 33 120
FAMOTIDINE 58 58 34 34
PANTOPRAZOLE SODIUM 58 37 34 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.